B
BriaCell Therapeutics Corp D
D
BCTX
10.310
USD
0.65
(6.73%)
مغلق
حجم التداول
1,707
الربح لكل سهم
-164
العائد الربحي
-
P/E
-0
حجم السوق
19,423,071
العنوان: Briacell Therapeutics Corp NEW
القطاع: Healthcare
الصناعة: Biotechnology
BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.